Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

684 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Study of EGFR-TKI Rechallenge With Another TKI After First-Line Osimertinib Discontinuation in Patients With EGFR-Mutated Non-Small Cell Lung Cancer: A Subset Analysis of the Reiwa Study.
Sonehara K, Tateishi K, Yoh K, Usui K, Hosomi Y, Kishi K, Naka G, Watanabe K, Tamano S, Uemura K, Kunitoh H. Sonehara K, et al. Among authors: usui k. Thorac Cancer. 2024 Dec 7. doi: 10.1111/1759-7714.15507. Online ahead of print. Thorac Cancer. 2024. PMID: 39644181 Free article.
Difference in efficacy of osimertinib between patients with EGFR-positive NSCLC with postoperative recurrence and those with de novo unresectable disease: A prospective, observational study.
Karayama M, Suda T, Yoh K, Usui K, Hosomi Y, Kishi K, Naka G, Watanabe K, Tamano S, Uemura K, Kunitoh H. Karayama M, et al. Among authors: usui k. Lung Cancer. 2024 Dec;198:108037. doi: 10.1016/j.lungcan.2024.108037. Epub 2024 Nov 26. Lung Cancer. 2024. PMID: 39602849
From the Laboratory to the Real-World: The Role of Mismatch Negativity in Psychosis.
Tada M, Yagishita S, Uka T, Nishimura R, Kishigami T, Kirihara K, Koshiyama D, Usui K, Fujioka M, Araki T, Kasai K. Tada M, et al. Among authors: usui k. Clin EEG Neurosci. 2024 Nov 6:15500594241294188. doi: 10.1177/15500594241294188. Online ahead of print. Clin EEG Neurosci. 2024. PMID: 39506274 Review.
Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case.
Kuwata T, Kaku Y, Biswas S, Matsumoto K, Shimizu M, Kawanami Y, Uraki R, Okazaki K, Minami R, Nagasaki Y, Nagashima M, Yoshida I, Sadamasu K, Yoshimura K, Ito M, Kiso M, Yamayoshi S, Imai M, Ikeda T, Sato K, Toyoda M, Ueno T, Inoue T, Tanaka Y, Kimura KT, Hashiguchi T, Sugita Y, Noda T, Morioka H, Kawaoka Y, Matsushita S; Genotype to Phenotype Japan (G2P-Japan) Consortium. Kuwata T, et al. EBioMedicine. 2024 Nov 1;110:105439. doi: 10.1016/j.ebiom.2024.105439. Online ahead of print. EBioMedicine. 2024. PMID: 39488016 Free PMC article.
The Whole Picture of First-Line Osimertinib for EGFR Mutation-Positive Advanced NSCLC: Real-World Efficacy, Safety, Progression Pattern, and Posttreatment Therapy (Reiwa Study).
Watanabe K, Hosomi Y, Naoki K, Nakahara Y, Tsukita Y, Matsumoto H, Yoh K, Fujisaka Y, Takahashi S, Takata S, Usui K, Kishi K, Naka G, Tamano S, Uemura K, Kunitoh H. Watanabe K, et al. Among authors: usui k. JTO Clin Res Rep. 2024 Sep 7;5(11):100720. doi: 10.1016/j.jtocrr.2024.100720. eCollection 2024 Nov. JTO Clin Res Rep. 2024. PMID: 39416709 Free PMC article.
Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1.
Yajima H, Anraku Y, Kaku Y, Kimura KT, Plianchaisuk A, Okumura K, Nakada-Nakura Y, Atarashi Y, Hemmi T, Kuroda D, Takahashi Y, Kita S, Sasaki J, Sumita H; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Maenaka K, Sato K, Hashiguchi T. Yajima H, et al. Nat Commun. 2024 Oct 7;15(1):8574. doi: 10.1038/s41467-024-52808-2. Nat Commun. 2024. PMID: 39375326 Free PMC article.
Comparative Analysis of Independent Reviewer-Rated and Self-Rated Fidelity Scores in Individual Placement and Support Programs: Repeated Cross-Sectional Surveys.
Yamaguchi S, Koike J, Igarashi M, Kawaguchi T, Shiozawa T, Usui K, Iwanaga M, Matsunaga A, Yoshida K, Sato S, Fujii C. Yamaguchi S, et al. Among authors: usui k. Adm Policy Ment Health. 2024 Sep 25. doi: 10.1007/s10488-024-01413-y. Online ahead of print. Adm Policy Ment Health. 2024. PMID: 39322777
10-year outcome trajectories of people with mental illness and their families who receive services from multidisciplinary case management and outreach teams: protocol of a multisite longitudinal study.
Yamaguchi S, Usui K, Iwanaga M, Kawaguchi T, Hada A, Yoshida K, Nishio M, Yanata H, Watanabe M, Taniguchi K, Aoki H, Hisajima Y, Sato S, Fujii C. Yamaguchi S, et al. Among authors: usui k. BMJ Open. 2024 Aug 31;14(8):e085532. doi: 10.1136/bmjopen-2024-085532. BMJ Open. 2024. PMID: 39298130 Free PMC article.
684 results